{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:05:19Z","timestamp":1772834719325,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41434-018-0014-y","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T15:47:04Z","timestamp":1523634424000},"page":"234-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of microRNA-292-5p on myocardial ischemia\u2013reperfusion injury through the peroxisome proliferator-activated receptor-\u03b1\/-\u03b3 signaling pathway"],"prefix":"10.1038","volume":"25","author":[{"given":"Zhen-Dong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Mei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Hua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00059-013-3790-6","volume":"38","author":"C Jacobshagen","year":"2013","unstructured":"Jacobshagen C, Maier LS. Pathophysiology of chronic myocardial ischemia. Herz. 2013;38:329\u201333.","journal-title":"Herz"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCRESAHA.116.308925","volume":"119","author":"G Heusch","year":"2016","unstructured":"Heusch G. Myocardial ischemia: lack of coronary blood flow or myocardial oxygen supply\/demand imbalance? Circ Res. 2016;119:194\u20136.","journal-title":"Circ Res"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1295","volume":"11","author":"R Shibata","year":"2005","unstructured":"Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al. Adiponectin protects against myocardial ischemia\u2013reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11:1096\u2013103.","journal-title":"Nat Med"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"17442","DOI":"10.3390\/ijms151017442","volume":"15","author":"CL Song","year":"2014","unstructured":"Song CL, Liu B, Diao HY, Shi YF, Li YX, Zhang JC, et al. The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia\u2013reperfusion injury in the rat model. Int J Mol Sci. 2014;15:17442\u201356.","journal-title":"Int J Mol Sci"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.1073\/pnas.1100286108","volume":"108","author":"J Fauconnier","year":"2011","unstructured":"Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y, et al. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia\u2013reperfusion. Proc Natl Acad Sci USA. 2011;108:13258\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia\u2013reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92\u2013100.","journal-title":"J Clin Invest"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"239ps233","DOI":"10.1126\/scitranslmed.3009008","volume":"6","author":"EN Olson","year":"2014","unstructured":"Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med. 2014;6:239ps233.","journal-title":"Sci Transl Med"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10557-011-6289-5","volume":"25","author":"VK Topkara","year":"2011","unstructured":"Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther. 2011;25:171\u201382.","journal-title":"Cardiovasc Drugs Ther"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5604\/17322693.1100348","volume":"68","author":"P Fic","year":"2014","unstructured":"Fic P, Kowalczuk K, Grabarska A, Stepulak A. MicroRNA\u2014a new diagnostic tool in coronary artery disease and myocardial infarction. Post Hig Med Dosw. 2014;68:410\u20138.","journal-title":"Post Hig Med Dosw"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1152\/physiolgenomics.00130.2010","volume":"43","author":"Y Ye","year":"2011","unstructured":"Ye Y, Perez-Polo JR, Qian J, Birnbaum Y. The role of microRNA in modulating myocardial ischemia\u2013reperfusion injury. Physiol Genom. 2011;43:534\u201342.","journal-title":"Physiol Genom"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/stem.1033","volume":"30","author":"P Luningschror","year":"2012","unstructured":"Luningschror P, Stocker B, Kaltschmidt B, Kaltschmidt C. miR-290 cluster modulates pluripotency by repressing canonical NF-kappaB signaling. Stem Cells. 2012;30:655\u201364.","journal-title":"Stem Cells"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"42613","DOI":"10.18632\/oncotarget.6073","volume":"6","author":"L Tao","year":"2015","unstructured":"Tao L, Bei Y, Zhou Y, Xiao J, Li X. Non-coding RNAs in cardiac regeneration. Oncotarget. 2015;6:42613\u201322.","journal-title":"Oncotarget"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1152\/physiolgenomics.00085.2009","volume":"39","author":"L Pitto","year":"2009","unstructured":"Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, et al. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genom. 2009;39:210\u20138.","journal-title":"Physiol Genom"},{"key":"14_CR14","first-page":"237","volume":"2","author":"JB Weiss","year":"2012","unstructured":"Weiss JB, Eisenhardt SU, Stark GB, Bode C, Moser M, Grundmann S. MicroRNAs in ischemia\u2013reperfusion injury. Am J Cardiovasc Dis. 2012;2:237\u201347.","journal-title":"Am J Cardiovasc Dis"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1139\/y2012-052","volume":"90","author":"T Ravingerova","year":"2012","unstructured":"Ravingerova T, Carnicka S, Nemcekova M, Ledvenyiova V, Adameova A, Kelly T, et al. PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia\u2013reperfusion injury: involvement of PI3K-Akt. Can J Physiol Pharmacol. 2012;90:1135\u201344.","journal-title":"Can J Physiol Pharmacol"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1476-5381.2011.01597.x","volume":"165","author":"P Balakumar","year":"2012","unstructured":"Balakumar P, Mahadevan N. Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword? Br J Pharmacol. 2012;165:373\u20139.","journal-title":"Br J Pharmacol"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/aps.2014.63","volume":"35","author":"Z Meng","year":"2014","unstructured":"Meng Z, Yu XH, Chen J, Li L, Li S. Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-gamma activation. Acta Pharmacol Sin. 2014;35:1247\u201356.","journal-title":"Acta Pharmacol Sin"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ibanez","year":"2015","unstructured":"Ibanez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia\/reperfusion injury. J Am Coll Cardiol. 2015;65:1454\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bcp.2011.04.004","volume":"82","author":"A Morrison","year":"2011","unstructured":"Morrison A, Li J. PPAR-gamma and AMPK--advantageous targets for myocardial ischemia\/reperfusion therapy. Biochem Pharmacol. 2011;82:195\u2013200.","journal-title":"Biochem Pharmacol"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1073\/pnas.1108586108","volume":"108","author":"E Mezzaroma","year":"2011","unstructured":"Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN, et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA. 2011;108:19725\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jss.2012.08.020","volume":"182","author":"B Reel","year":"2013","unstructured":"Reel B, Guzeloglu M, Bagriyanik A, Atmaca S, Aykut K, Albayrak G, et al. The effects of PPAR-gamma agonist pioglitazone on renal ischemia\/reperfusion injury in rats. J Surg Res. 2013;182:176\u201384.","journal-title":"J Surg Res"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1172\/JCI10373","volume":"107","author":"T Collins","year":"2001","unstructured":"Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 2001;107:255\u201364.","journal-title":"J Clin Invest"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557\u201366.","journal-title":"Nat Med"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fphys.2014.00429","volume":"5","author":"Y Lecarpentier","year":"2014","unstructured":"Lecarpentier Y, Claes V, Duthoit G, Hebert JL. Circadian rhythms, Wnt\/beta-catenin pathway and PPAR alpha\/gamma profiles in diseases with primary or secondary cardiac dysfunction. Front Physiol. 2014;5:429.","journal-title":"Front Physiol"},{"key":"14_CR25","first-page":"653017","volume":"2014","author":"L Chen","year":"2014","unstructured":"Chen L, Yang G. PPARs integrate the mammalian clock and energy metabolism. PPAR Res. 2014;2014:653017.","journal-title":"PPAR Res"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00395-011-0162-3","volume":"106","author":"Y Birnbaum","year":"2011","unstructured":"Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-gamma-independent manner. Basic Res Cardiol. 2011;106:431\u201346.","journal-title":"Basic Res Cardiol"},{"key":"14_CR27","first-page":"BR243","volume":"8","author":"NS Wayman","year":"2002","unstructured":"Wayman NS, Ellis BL, Thiemermann C. Ligands of the peroxisome proliferator-activated receptor-PPAR-a reduce myocardial infarct size. Med Sci Monit. 2002;8:BR243\u2013247.","journal-title":"Med Sci Monit"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.10.021","volume":"130","author":"GJL Sundararajan S","year":"2005","unstructured":"Sundararajan S GJL, Victor NA, et al. PPAR\u03b3 ligands reduce inflammation and infarction size in transient focal ischemia[J]. Neuroscience. 2005;130:685\u201396.","journal-title":"Neuroscience"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res. 2008;102:283\u201394.","journal-title":"Circ Res"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1172\/JCI30335","volume":"117","author":"NH Son","year":"2007","unstructured":"Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007;117:2791\u2013801.","journal-title":"J Clin Invest"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tox.2012.11.022","volume":"307","author":"G Velmurugan","year":"2013","unstructured":"Velmurugan G, Venkatesh Babu DD, Ramasamy S. Prolonged monocrotophos intake induces cardiac oxidative stress and myocardial damage in rats. Toxicology. 2013;307:103\u20138.","journal-title":"Toxicology"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4330\/wjc.v5.i6.164","volume":"5","author":"T Kim","year":"2013","unstructured":"Kim T, Yang Q. Peroxisome proliferator-activated receptors regulate redox signaling in the cardiovascular system. World J Cardiol. 2013;5:164\u201374.","journal-title":"World J Cardiol"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jocn.2010.09.025","volume":"18","author":"O Bloch","year":"2011","unstructured":"Bloch O, Sughrue ME, Mills SA, Parsa AT. Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy. J Clin Neurosci. 2011;18:881\u20135.","journal-title":"J Clin Neurosci"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/bph.12431","volume":"171","author":"MJ Roy","year":"2014","unstructured":"Roy MJ, Vom A, Czabotar PE, Lessene G. Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway. Br J Pharmacol. 2014;171:1973\u201387.","journal-title":"Br J Pharmacol"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tem.2015.01.005","volume":"26","author":"RR Mason","year":"2015","unstructured":"Mason RR, Watt MJ. Unraveling the roles of PLIN5: linking cell biology to physiology. Trends Endocrinol Metab. 2015;26:144\u201352.","journal-title":"Trends Endocrinol Metab"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2133\/dmpk.DMPK-13-NT-139","volume":"29","author":"T Katano","year":"2014","unstructured":"Katano T, Ito Y, Ohta K, Yasujima T, Inoue K, Yuasa H. Competitive inhibition of AQP7-mediated glycerol transport by glycerol derivatives. Drug Metab Pharmacokinet. 2014;29:348\u201351.","journal-title":"Drug Metab Pharmacokinet"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"e44907","DOI":"10.1371\/journal.pone.0044907","volume":"7","author":"R Li","year":"2012","unstructured":"Li R, Yan G, Li Q, Sun H, Hu Y, Sun J, et al. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS ONE. 2012;7:e44907.","journal-title":"PLoS ONE"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0014-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:21Z","timestamp":1684617201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-018-0014-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1038\/s41434-018-0014-y","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"1 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}